Mass Spectrometry & Spectroscopy
Bruker Launches the INVENIO X FTIR Research Spectrometer
Nov 08 2019 Read 450 Times
Bruker announced on 25 September 2019 the launch of the novel INVENIO X FTIR research system for research in molecular spectroscopy. This intuitive, modular, new advanced R&D spectrometer further expands Bruker’s next- generation INVENIO® FTIR R&D platform. The INVENIO X is designed for the most demanding analytical applications, and now offers new capabilities for advanced research & development.
The INVENIO platform was introduced in 2018 and offers beneficial MultiTect™ technology for mounting up to 5 detectors, as well as the unique FM functionality for simultaneous mid- and far-infrared spectroscopy. The INVENIO X is available with an automated 3-position beam splitter changer, and its wear-free, novel INTEGRAL™ interferometer combines high spectral resolution of <0.09 cm-1 with the accuracy of cube corner mirrors.
“With up to seven software-controlled detectors and multiple light source options, INVENIO X is the most highly automated, multispectral research spectrometer,” said Dr. Michael Joerger, Bruker Product Line Manager for FTIR R&D systems. “This permits measurements from the far IR to the UV/VIS range without the manual exchange of any optical components.”
In addition, INVENIO X benefits from other features introduced with the INVENIO platform. Its novel beam path improves spectroscopic sensitivity, and system-on-a-chip (SoC) built-in intelligence ensures faster data acquisition and processing. Its optional Transit™ channel enables quick measurements without removing longer-term experiments from the main sample compartment. Coded beam windows with magnetic mounts, an automated internal attenuator, an 8-position validation wheel, and an optional integrated touch panel for intuitive spectroscopic workflows represent further smart INVENIO innovations.
For more information on INVENIO, please click here.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - The Separation and Purification of Glutamine Deri...
View all digital editions
Nov 25 2019 Beijing, China
Dec 05 2019 New Delhi, India
Dec 13 2019 Kathmandu, Nepal
Jan 25 2020 San Diego, CA, USA
Jan 27 2020 Dubai, UAE